OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Transforming Growth Factor-Beta (TGF-β) Signaling in Cancer-A Betrayal Within
Abdul Basit Baba, Bilal Rah, Gh Rasool Bhat, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 131

Showing 1-25 of 131 citing articles:

Pathobiology of the Klotho Antiaging Protein and Therapeutic Considerations
Gérald J. Prud’homme, Mervé Kurt, Qinghua Wang
Frontiers in Aging (2022) Vol. 3
Open Access | Times Cited: 118

Targeting inflammation as cancer therapy
Manni Wang, Siyuan Chen, Xuemei He, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 30

CircRNAs: Pivotal modulators of TGF-β signalling in cancer pathogenesis
Asif Ahmad Bhat, Gaurav Gupta, Rajiv Dahiya, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 2, pp. 277-287
Open Access | Times Cited: 16

Cytokines and soluble mediators as architects of tumor microenvironment reprogramming in cancer therapy
Suling Xu, Qing-Qing Wang, Wenxue Ma
Cytokine & Growth Factor Reviews (2024) Vol. 76, pp. 12-21
Closed Access | Times Cited: 12

Micropeptides: potential treatment strategies for cancer
Zhou He, Yan Wu, Cai Ji, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 8

Telomerase and hallmarks of cancer: An intricate interplay governing cancer cell evolution
Naveen Kumar, Gautam Sethi
Cancer Letters (2023) Vol. 578, pp. 216459-216459
Closed Access | Times Cited: 21

Unveiling the Immune Microenvironment’s Role in Breast Cancer: A Glimpse into Promising Frontiers
Amalia Kotsifaki, Nektarios Alevizopoulos, Vassiliki Dimopoulou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15332-15332
Open Access | Times Cited: 21

Targeting Signalling Pathways in Chronic Wound Healing
L. Bonnici, Sherif Suleiman, Pierre Schembri-Wismayer, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 50-50
Open Access | Times Cited: 19

Tumor-associated fibrosis impairs the response to immunotherapy
Angha Naik, Andrew Leask
Matrix Biology (2023) Vol. 119, pp. 125-140
Closed Access | Times Cited: 18

Spatial resolution of cellular senescence dynamics in human colorectal liver metastasis
Ombretta Garbarino, Luca Lambroia, Gianluca Basso, et al.
Aging Cell (2023) Vol. 22, Iss. 7
Open Access | Times Cited: 17

Navigating the Cytokine Seas: Targeting Cytokine Signaling Pathways in Cancer Therapy
Noyko Stanilov, Tsvetelina Velikova, С. Станилова
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1009-1009
Open Access | Times Cited: 6

Different origin-derived exosomes and their clinical advantages in cancer therapy
Xiaoyan Jin, Jing Zhang, Yufu Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6

Unraveling the complexities of colorectal cancer and its promising therapies – An updated review
Sayan Saha, Shreya Ghosh, Suman Ghosh, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113325-113325
Closed Access | Times Cited: 6

Mechanisms of Prostate Cancer Cells Survival and Their Therapeutic Targeting
T. Pejcic, Zoran Todorović, Siniša Đurašević, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2939-2939
Open Access | Times Cited: 13

Application of Nanotechnology and Phytochemicals in Anticancer Therapy
Jin Hee Kim, Boluwatife Olamide Dareowolabi, Rekha Thiruvengadam, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1169-1169
Open Access | Times Cited: 5

The Impact of Klotho in Cancer: From Development and Progression to Therapeutic Potential
Miguel Á. Ortega, Diego Liviu Boaru, Diego De León-Oliva, et al.
Genes (2025) Vol. 16, Iss. 2, pp. 128-128
Open Access

Photobiomodulation mitigates doxorubicin resistance in MDA-MB-231 breast cancer cells: a promising avenue for overcoming chemoresistance
Fatemeh Javani Jouni, Nima Rastegar‐Pouyani, Ahmad Moshaii, et al.
Lasers in Medical Science (2025) Vol. 40, Iss. 1
Closed Access

Impact of G1 phase kinetics on the acquisition of stemness in cancer cells: the critical role of cyclin D
Yasin Ahmadi, Tahran Faiq, Sakhavat Abolhasani
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access

Exploring TGF-β Signaling in Cancer Progression: Prospects and Therapeutic Strategies
Khursheed Ahmad Sheikh, Momna Amjad, Mohammad Irfan, et al.
OncoTargets and Therapy (2025) Vol. Volume 18, pp. 233-262
Open Access

Advanced Therapeutic Approaches for Metastatic Ovarian Cancer
Soohyun Choe, Mir Jeon, Hyunho Yoon
Cancers (2025) Vol. 17, Iss. 5, pp. 788-788
Open Access

Signal transduction pathway activity in adult-type granulosa cell tumor samples
Geertruid J. Brink, Jolijn W. Groeneweg, Phyllis van der Ploeg, et al.
Gynecologic Oncology (2025) Vol. 195, pp. 6-11
Open Access

Pathway-specific genomic alterations in pancreatic cancer across diverse cohorts
Cecilia Monge, Brigette Waldrup, Francisco J. Carranza-Chávez, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access

ALDH1A1 in breast cancer: A prospective target to overcome therapy resistance (Review)
Lokman Varışlı, Panagiotis Zoumpourlis, Demetrios�� Spandidos, et al.
Oncology Letters (2025) Vol. 29, Iss. 5, pp. 1-17
Open Access

Page 1 - Next Page

Scroll to top